Semanteon Capital Management LP Acquires 213 Shares of The Clorox Company (NYSE:CLX)

Semanteon Capital Management LP increased its stake in The Clorox Company (NYSE:CLX) by 3.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,298 shares of the company’s stock after buying an additional 213 shares during the period. Semanteon Capital Management LP’s holdings in Clorox were worth $1,026,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CLX. Innealta Capital LLC purchased a new position in Clorox during the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period. First Foundation Advisors bought a new stake in Clorox during the 1st quarter valued at $31,000. Family Firm Inc. bought a new position in shares of Clorox in the 2nd quarter worth $31,000. Finally, Quarry LP raised its position in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CLX. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price on the stock. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. DA Davidson restated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, Barclays raised their price objective on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a research report on Friday, October 11th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus target price of $150.14.

Clorox Stock Performance

CLX traded up $1.27 during trading on Monday, reaching $157.96. 134,861 shares of the company’s stock were exchanged, compared to its average volume of 1,217,983. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09. The company’s fifty day simple moving average is $160.74 and its 200-day simple moving average is $145.63. The stock has a market capitalization of $19.62 billion, a P/E ratio of 81.19, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. As a group, research analysts predict that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.09%. Clorox’s payout ratio is 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.